Medtech execs share secrets to building resilient supply chains

At AdvaMed’s The MedTech Conference, company executives said they’re bracing for disruption by investing in inventory, scenario planning and their relationships with chip suppliers.

BOSTON — In an era of heightened tariff volatility and geopolitical risk, medtech companies are rewriting their supply chain playbooks to ensure patients have uninterrupted access to critical therapies, executives said Monday at AdvaMed’s The MedTech Conference.

After coping with semiconductor shortages during the COVID-19 pandemic and tariff pressures, medtech companies are facing another semiconductor crisis in 2026, said Jon Rennert, chairman of Zoll Medical, a maker of automated external defibrillators and other devices for emergency and critical care. The artificial intelligence infrastructure buildout has medical device makers competing with demand from data centers for semiconductor chips.

“There's been more supply chain disruption to the medtech industry in the last five years than at any point that I've seen in my career, and I imagine many of you feel the same way,” Rennert told a conference audience.

This story was originally published by Supply Chain Dive. Read the full story at Supply Chain Dive →